Catalent today announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, and Thomas Castellano, Vice President Finance, Investor Relations and Treasurer will present at the following conferences in the coming weeks.
SOMERSET, N.J.--(BUSINESS WIRE)-- Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Wetteny Joseph, Senior Vice President & Chief Financial Officer, and Thomas Castellano, Vice President Finance, Investor Relations and Treasurer will present at the following conferences in the coming weeks.
2018 RBC Capital Markets Global Healthcare Conference
Location: New York, NY
Date: Thursday, February 22, 2018
Presentation: 11:00 a.m. ET
Raymond James 39th Annual Institutional Investors Conference
Location: Orlando, FL
Date: Monday, March 5, 2018
Presentation: 11:00 a.m. ET
A live webcast of the presentations will be accessible through the Company’s website at http://investor.catalent.com and will be available for replay following the event.
About Catalent, Inc.
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 10,000 people, including over 1,400 scientists, at more than 30 facilities across 5 continents and in fiscal 2017 generated more than $2 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source version on businesswire.com: http://www.businesswire.com/news/home/20180215006217/en/
Source: Catalent, Inc.
View this news release online at:
http://www.businesswire.com/news/home/20180215006217/en
